N Sangster-Guity, BH Conrad, N Papadopoulos… - Oncogene, 2011 - nature.com The protein kinase encoded by the ataxia telangiectasia and Rad3-related (ATR) gene is activated by DNA-damaging agents that are frequently used as anticancer therapeutics. Inhibition of ATR expression in cultured cancer cells has been demonstrated to increase sensitivity to ... Related articles - All 3 versions
JW Albers, V Chaudhry, G Cavaletti… - Cochrane database of …, 2011 - ncbi.nlm.nih.gov Interventions for preventing neuropathy caused by cisplatin and related compounds. ... Albers JW, Chaudhry V, Cavaletti G, Donehower RC. ... Department of Neurology, University of Michigan, 1C325/0032 University Hospital, 1500 E. Medical Center Drive, Box 0316, Ann ... Cited by 5 - Related articles - All 2 versions
GC CHANG, MJ AHN, E WRIGHT… - Asia‐Pacific Journal …, 2011 - Wiley Online Library E Wright and S Walzer are employed by F. Hoffmann-La Roche AG, Basel, Switzerland and S Walzer holds shares in F. Hoffmann-La Roche Ltd. Ahn MJ is on the bevacizumab advisory board advising on its pharmacoeconomic study in NSCLC. JH Kim has previously received a ... Cited by 2 - Related articles
CR Sears… - … Journal of Respiratory and Critical Care …, 2011 - Am Thoracic Soc Lung cancer is the leading cause of cancer deaths with most diagnosed as advanced-stage non-small cell lung cancer (NSCLC). The mainstay of medical treatment includes platinum-based chemotherapy and ionizing radiation (IR). Cisplatin produces bulky cisplatin-DNA ...
JWC CHANG, S THONGPRASERT… - Asia‐Pacific Journal …, 2011 - Wiley Online Library E Wright and S Walzer are employed by F. Hoffmann-La Roche AG, S. Walzer holds shares in F. Hoffmann-La Roche Ltd., S Thongprasert received research funding from F. Hoffman-La Roche and Genentech. MJ Ahn is a part of bevacizumab advisory board advising on its ... Cited by 3 - Related articles
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
